A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Clinical trial NCT07599813 · RECRUITING

Trial details

NCT number: NCT07599813
Sponsor: Apollo Therapeutics Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Atopic Dermatitis Dermatitis, Atopic Dermatologic Disease Eczema Eczema Atopic Dermatitis Eczema, Atopic

Start date: 2026-05-28
Primary completion: 2027-10-31
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.